$ABT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ABBOTT LABORATORIES.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ABBOTT LABORATORIES. Get notifications about new insider transactions in ABBOTT LABORATORIES for free.
Page: < prev 1 ... 4 5 6 7 8 9 10 11 12 ... 53 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.87 | 107 | 6,513 | 7,012,839 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.86 | 1,200 | 73,032 | 7,012,732 | 7 M to 7 M (+0.02 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.86 | 293 | 17,831 | 7,011,532 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.85 | 1,000 | 60,850 | 7,011,239 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.85 | 100 | 6,085 | 7,010,239 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.84 | 1,000 | 60,840 | 7,010,139 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.83 | 600 | 36,498 | 7,009,139 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.82 | 200 | 12,164 | 7,008,539 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.82 | 400 | 24,326 | 7,008,339 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.81 | 900 | 54,729 | 7,007,939 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.81 | 100 | 6,081 | 7,007,039 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.80 | 400 | 24,320 | 7,006,939 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.80 | 300 | 18,239 | 7,006,539 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.79 | 800 | 48,632 | 7,006,239 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.79 | 400 | 24,314 | 7,005,439 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.78 | 2,100 | 127,638 | 7,005,039 | 7 M to 7 M (+0.03 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.78 | 200 | 12,155 | 7,002,939 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.77 | 2,100 | 127,617 | 7,002,739 | 7 M to 7 M (+0.03 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.77 | 600 | 36,459 | 7,000,639 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.76 | 2,500 | 151,900 | 7,000,039 | 7 M to 7 M (+0.04 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.76 | 175 | 10,632 | 6,997,539 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.75 | 2,200 | 133,650 | 6,997,364 | 7 M to 7 M (+0.03 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.75 | 1,100 | 66,820 | 6,995,164 | 7 M to 7 M (+0.02 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.74 | 200 | 12,149 | 6,994,064 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.74 | 2,000 | 121,480 | 6,993,864 | 7 M to 7 M (+0.03 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.74 | 400 | 24,294 | 6,991,864 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.73 | 2,200 | 133,606 | 6,991,464 | 7 M to 7 M (+0.03 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.73 | 1,079 | 65,522 | 6,989,264 | 7 M to 7 M (+0.02 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.72 | 4,900 | 297,528 | 6,988,185 | 7 M to 7 M (+0.07 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.72 | 1,317 | 79,962 | 6,983,285 | 7 M to 7 M (+0.02 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.71 | 100 | 6,071 | 6,981,968 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.71 | 8,100 | 491,751 | 6,981,868 | 7 M to 7 M (+0.12 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.71 | 700 | 42,494 | 6,973,768 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.70 | 4,800 | 291,360 | 6,973,068 | 7 M to 7 M (+0.07 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.70 | 500 | 30,348 | 6,968,268 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.69 | 4,400 | 267,036 | 6,967,768 | 7 M to 7 M (+0.06 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.69 | 487 | 29,554 | 6,963,368 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.68 | 4,500 | 273,060 | 6,962,881 | 7 M to 7 M (+0.06 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.68 | 103 | 6,250 | 6,958,381 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.67 | 2,799 | 169,815 | 6,958,278 | 7 M to 7 M (+0.04 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.67 | 600 | 36,399 | 6,955,479 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.66 | 1,600 | 97,056 | 6,954,879 | 7 M to 7 M (+0.02 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.65 | 1,600 | 97,040 | 6,953,279 | 7 M to 7 M (+0.02 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.65 | 1,500 | 90,968 | 6,951,679 | 7 M to 7 M (+0.02 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.64 | 1,300 | 78,832 | 6,950,179 | 6.9 M to 7 M (+0.02 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.64 | 200 | 12,127 | 6,948,879 | 6.9 M to 6.9 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.63 | 700 | 42,441 | 6,948,679 | 6.9 M to 6.9 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.62 | 1,417 | 85,899 | 6,947,979 | 6.9 M to 6.9 M (+0.02 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.61 | 600 | 36,366 | 6,946,562 | 6.9 M to 6.9 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.61 | 14 | 848 | 6,945,962 | 6.9 M to 6.9 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.60 | 700 | 42,420 | 6,945,948 | 6.9 M to 6.9 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.60 | 100 | 6,060 | 6,945,248 | 6.9 M to 6.9 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.59 | 600 | 36,354 | 6,945,148 | 6.9 M to 6.9 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.58 | 100 | 6,058 | 6,944,548 | 6.9 M to 6.9 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.58 | 100 | 6,058 | 6,944,448 | 6.9 M to 6.9 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.57 | 400 | 24,228 | 6,944,348 | 6.9 M to 6.9 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.56 | 500 | 30,280 | 6,943,948 | 6.9 M to 6.9 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.53 | 100 | 6,053 | 6,943,448 | 6.9 M to 6.9 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.52 | 100 | 6,052 | 6,943,348 | 6.9 M to 6.9 M (0.00 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | LANE ANDREW H | Executive Vice Pres ... | Option Exercise | A | 59.94 | 182,935 | 10,965,124 | 182,935 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | LANE ANDREW H | Executive Vice Pres ... | Payment of Exercise | F | 60.17 | 605 | 36,403 | 22,294 | 22.9 K to 22.3 K (-2.64 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Option Exercise | A | 59.94 | 61,192 | 3,667,848 | 61,192 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Grant | A | 0.00 | 11,127 | 0 | 33,162 | 22 K to 33.2 K (+50.50 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.86 | 900 | 53,874 | 184,884 | 185.8 K to 184.9 K (-0.48 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.86 | 100 | 5,986 | 185,784 | 185.9 K to 185.8 K (-0.05 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.86 | 400 | 23,942 | 185,884 | 186.3 K to 185.9 K (-0.21 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.85 | 1,000 | 59,850 | 186,284 | 187.3 K to 186.3 K (-0.53 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.84 | 1,100 | 65,824 | 187,284 | 188.4 K to 187.3 K (-0.58 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.83 | 1,832 | 109,609 | 188,384 | 190.2 K to 188.4 K (-0.96 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.82 | 200 | 11,964 | 190,216 | 190.4 K to 190.2 K (-0.11 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.82 | 1,200 | 71,778 | 190,416 | 191.6 K to 190.4 K (-0.63 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.81 | 100 | 5,981 | 191,616 | 191.7 K to 191.6 K (-0.05 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.81 | 100 | 5,981 | 191,716 | 191.8 K to 191.7 K (-0.05 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.80 | 1,500 | 89,700 | 191,816 | 193.3 K to 191.8 K (-0.78 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.80 | 200 | 11,959 | 193,316 | 193.5 K to 193.3 K (-0.10 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.79 | 600 | 35,874 | 193,516 | 194.1 K to 193.5 K (-0.31 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.79 | 304 | 18,175 | 194,116 | 194.4 K to 194.1 K (-0.16 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.78 | 900 | 53,802 | 194,420 | 195.3 K to 194.4 K (-0.46 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.78 | 1,300 | 77,708 | 195,320 | 196.6 K to 195.3 K (-0.66 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.77 | 2,500 | 149,425 | 196,620 | 199.1 K to 196.6 K (-1.26 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.77 | 740 | 44,226 | 199,120 | 199.9 K to 199.1 K (-0.37 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.76 | 3,419 | 204,319 | 199,860 | 203.3 K to 199.9 K (-1.68 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.76 | 1,700 | 101,584 | 203,279 | 205 K to 203.3 K (-0.83 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.75 | 3,100 | 185,225 | 204,979 | 208.1 K to 205 K (-1.49 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.75 | 106 | 6,333 | 208,079 | 208.2 K to 208.1 K (-0.05 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.74 | 600 | 35,844 | 208,185 | 208.8 K to 208.2 K (-0.29 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.74 | 116 | 6,929 | 208,785 | 208.9 K to 208.8 K (-0.06 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.73 | 1,600 | 95,568 | 208,901 | 210.5 K to 208.9 K (-0.76 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.73 | 100 | 5,973 | 210,501 | 210.6 K to 210.5 K (-0.05 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.73 | 628 | 37,507 | 210,601 | 211.2 K to 210.6 K (-0.30 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.72 | 1,294 | 77,278 | 211,229 | 212.5 K to 211.2 K (-0.61 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.71 | 2,900 | 173,159 | 212,523 | 215.4 K to 212.5 K (-1.35 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.71 | 200 | 11,941 | 215,423 | 215.6 K to 215.4 K (-0.09 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.70 | 1,900 | 113,430 | 215,623 | 217.5 K to 215.6 K (-0.87 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.70 | 901 | 53,785 | 217,523 | 218.4 K to 217.5 K (-0.41 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.69 | 2,300 | 137,287 | 218,424 | 220.7 K to 218.4 K (-1.04 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.69 | 2,999 | 178,995 | 220,724 | 223.7 K to 220.7 K (-1.34 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.68 | 2,774 | 165,552 | 223,723 | 226.5 K to 223.7 K (-1.22 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.68 | 600 | 35,805 | 226,497 | 227.1 K to 226.5 K (-0.26 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.67 | 6,028 | 359,691 | 227,097 | 233.1 K to 227.1 K (-2.59 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 38.40 | 104,642 | 4,018,253 | 104,642 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | A | 59.94 | 246,963 | 14,802,962 | 246,963 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.67 | 100 | 5,967 | 233,125 | 233.2 K to 233.1 K (-0.04 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.67 | 77 | 4,594 | 233,225 | 233.3 K to 233.2 K (-0.03 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.67 | 2,985 | 178,100 | 233,302 | 236.3 K to 233.3 K (-1.26 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.66 | 8,206 | 489,570 | 236,287 | 244.5 K to 236.3 K (-3.36 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.66 | 10 | 597 | 244,493 | 244.5 K to 244.5 K (0.00 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.66 | 3,200 | 190,896 | 244,503 | 247.7 K to 244.5 K (-1.29 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.65 | 4,794 | 285,962 | 247,703 | 252.5 K to 247.7 K (-1.90 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.65 | 600 | 35,787 | 252,497 | 253.1 K to 252.5 K (-0.24 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.64 | 1,700 | 101,388 | 253,097 | 254.8 K to 253.1 K (-0.67 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.64 | 500 | 29,818 | 254,797 | 255.3 K to 254.8 K (-0.20 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.63 | 1,600 | 95,408 | 255,297 | 256.9 K to 255.3 K (-0.62 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.60 | 22,500 | 1,341,000 | 256,897 | 279.4 K to 256.9 K (-8.05 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.60 | 100 | 5,960 | 279,397 | 279.5 K to 279.4 K (-0.04 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.59 | 500 | 29,795 | 279,497 | 280 K to 279.5 K (-0.18 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.59 | 500 | 29,793 | 279,997 | 280.5 K to 280 K (-0.18 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.58 | 500 | 29,790 | 280,497 | 281 K to 280.5 K (-0.18 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.56 | 180 | 10,721 | 280,997 | 281.2 K to 281 K (-0.06 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.55 | 574 | 34,179 | 281,177 | 281.8 K to 281.2 K (-0.20 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.54 | 226 | 13,456 | 281,751 | 282 K to 281.8 K (-0.08 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.53 | 989 | 58,875 | 281,977 | 283 K to 282 K (-0.35 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.52 | 728 | 43,331 | 282,966 | 283.7 K to 283 K (-0.26 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.52 | 200 | 11,903 | 283,694 | 283.9 K to 283.7 K (-0.07 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.51 | 1,172 | 69,746 | 283,894 | 285.1 K to 283.9 K (-0.41 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.50 | 1,200 | 71,400 | 285,066 | 286.3 K to 285.1 K (-0.42 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.50 | 441 | 26,237 | 286,266 | 286.7 K to 286.3 K (-0.15 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.49 | 1,419 | 84,416 | 286,707 | 288.1 K to 286.7 K (-0.49 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.48 | 300 | 17,844 | 288,126 | 288.4 K to 288.1 K (-0.10 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.47 | 1,100 | 65,417 | 288,426 | 289.5 K to 288.4 K (-0.38 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 38.40 | 104,642 | 4,018,253 | 289,526 | 184.9 K to 289.5 K (+56.60 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Grant | A | 0.00 | 44,909 | 0 | 184,884 | 140 K to 184.9 K (+32.08 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Option Exercise | A | 59.94 | 246,963 | 14,802,962 | 246,963 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Grant | A | 0.00 | 44,909 | 0 | 97,075 | 52.2 K to 97.1 K (+86.09 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Option Exercise | A | 59.94 | 110,146 | 6,602,151 | 110,146 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Grant | A | 0.00 | 20,030 | 0 | 108,367 | 88.3 K to 108.4 K (+22.67 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | A | 59.94 | 110,146 | 6,602,151 | 110,146 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Grant | A | 0.00 | 20,030 | 0 | 65,369 | 45.3 K to 65.4 K (+44.18 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | A | 59.94 | 155,495 | 9,320,370 | 155,495 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Grant | A | 0.00 | 28,276 | 0 | 306,258 | 278 K to 306.3 K (+10.17 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | BRYNELSEN CHARLES | Senior Vice Preside ... | Option Exercise | A | 59.94 | 110,146 | 6,602,151 | 110,146 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | BRYNELSEN CHARLES | Senior Vice Preside ... | Grant | A | 0.00 | 20,030 | 0 | 30,010 | 10 K to 30 K (+200.70 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Bracken Sharon J | Senior Vice Preside ... | Option Exercise | A | 59.94 | 134,623 | 8,069,303 | 134,623 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Bracken Sharon J | Senior Vice Preside ... | Grant | A | 0.00 | 24,481 | 0 | 49,499 | 25 K to 49.5 K (+97.85 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Option Exercise | A | 59.94 | 201,229 | 12,061,666 | 201,229 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Grant | A | 0.00 | 36,593 | 0 | 165,447 | 128.9 K to 165.4 K (+28.40 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | BIRD ROGER | Senior Vice Preside ... | Option Exercise | A | 59.94 | 122,385 | 7,335,757 | 122,385 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | BIRD ROGER | Senior Vice Preside ... | Grant | A | 0.00 | 22,255 | 0 | 73,568 | 51.3 K to 73.6 K (+43.37 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | ALLEN HUBERT L | Executive Vice Pres ... | Option Exercise | A | 59.94 | 246,963 | 14,802,962 | 246,963 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | ALLEN HUBERT L | Executive Vice Pres ... | Grant | A | 0.00 | 44,909 | 0 | 145,788 | 100.9 K to 145.8 K (+44.52 %) |